12:00 AM
 | 
May 05, 2004
 |  BC Extra  |  Company News

INNX, Advanced Biotherapy interferon gamma deal

Innogenetics (Euronext: INNX) and ADVB cross-licensed their respective interferon gamma IP related to...

Read the full 48 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >